Cdk1 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cdk1 monoclonal antibodies for research in cell cycle regulation and related processes. Cdk1 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdk1, or Cyclin-dependent kinase 1, plays a crucial role in the regulation of the cell cycle, particularly in the transition from G2 phase to mitosis. Its activity is tightly controlled by cyclins and various regulatory proteins, making it essential for proper cell division and proliferation. Dysregulation of Cdk1 has been implicated in various cancers, highlighting its importance as a target for therapeutic intervention. Cdk1 monoclonal antibodies enable precise detection and quantification of Cdk1 expression levels in different cellular states. Understanding Cdk1 activity patterns helps researchers identify potential therapeutic targets in cancer treatment. Investigating Cdk1 regulation mechanisms provides insights into cell cycle checkpoints and their role in disease progression. Santa Cruz Biotechnology monoclonal antibodies for Cdk1 support researchers worldwide in advancing our understanding of cell cycle regulation and developing new cancer treatments.